-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QG4B1nNqKkUNioArwUk7YIKwo9xbRJ37T8k8G8/e9zjBhD5paa14nXV26lFD0ofp cC7qKsw2Zsg+ghCUkLJnbw== 0001104659-06-068010.txt : 20061023 0001104659-06-068010.hdr.sgml : 20061023 20061023171134 ACCESSION NUMBER: 0001104659-06-068010 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061017 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20061023 DATE AS OF CHANGE: 20061023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 061158353 BUSINESS ADDRESS: STREET 1: 101 GORDON DR STREET 2: P O BOX 645 CITY: LIONVILLE STATE: PA ZIP: 19341-0645 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 101 GORDON DRIVE STREET 2: PO BOX 645 CITY: LIONVILLE STATE: PA ZIP: 19341-0645 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 8-K 1 a06-22512_18k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported) — October 17,  2006

 

 

WEST PHARMACEUTICAL SERVICES, INC.


(Exact name of registrant as specified in its charter)

 

 

Pennsylvania

 

1-8036

 

23-1210010

(State or other jurisdiction

 

(Commission File Number)

 

(IRS Employer

of incorporation)

 

 

 

Identification No.)

 

101 Gordon Drive, PO Box 645, Lionville, PA

 

19341-0645

(Address of principal executive offices)

 

(Zip Code)

 

610-594-3319

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

 

o

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

 

o

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

 

o

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 1.01         Entry into a Material Definitive Agreement.

 

On October 17, 2006 the Board of Directors of West Pharmaceutical Services, Inc. (the “Company”) amended the Company’s Non-Qualified Deferred Compensation Plan for Designated Officers, as amended and restated effective January 1, 2004.  The amendments, which will become effective January 1, 2007, will make the following material changes:

·                  Expand eligibility for participation to include Company employees with an annual base salary of at least $150,000; and

·                  Convert the Plan to an “excess” plan, so that the matching contribution formula, vesting schedule and other terms will be substantially identical to those contained in the Company’s 401(k) Savings Plan.

In conjunction with these amendments, the Board also adopted amendments to the Company’s 401(k) Savings Plan to conform to “safe-harbor” formulas for vesting and matching contributions, thereby allowing broader participation in Savings Plan for highly compensated employees.  The changes to the Savings Plan also will become effective as of January 1, 2007.



 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

WEST PHARMACEUTICAL SERVICES, INC.

 

 

 

 

 

/s/ John R. Gailey III

 

John R. Gailey III

 

Vice President, General Counsel and Secretary

 

October 23, 2006

 


 -----END PRIVACY-ENHANCED MESSAGE-----